Chronic imatinib (> 3 years) therapy after complete resection of primary, high-risk gastrointestinal stromal tumor (GIST) is associated with low recurrence Meeting Abstract


Authors: Cavnar, M. J.; Balachandran, V. P.; Chi, P.; Keohan, M. L.; Tap, W. D.; DeMatteo, R. P.
Abstract Title: Chronic imatinib (> 3 years) therapy after complete resection of primary, high-risk gastrointestinal stromal tumor (GIST) is associated with low recurrence
Meeting Title: 102nd Annual Clinical Congress of the American College of Surgeons (ACS)/2nd Owen H Wangensteen Scientific Forum
Journal Title: Journal of the American College of Surgeons
Volume: 223
Issue: 4 Suppl. 2
Meeting Dates: 2016 Oct 16-20
Meeting Location: Washington, DC
ISSN: 1072-7515
Publisher: Elsevier Science, Inc.  
Date Published: 2016-10-01
Start Page: e44
Language: English
ACCESSION: WOS:000395825100094
PROVIDER: wos
DOI: 10.1016/j.jamcollsurg.2016.08.544
Notes: Meeting Abstract -- Clinical Congress and Scientific Forum of the American-College-of-Surgeons -- OCT 16-20, 2016 -- Washington, DC -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ronald P DeMatteo
    637 DeMatteo
  2. Ping Chi
    173 Chi
  3. Mary Louise Keohan
    125 Keohan
  4. Michael Joseph Cavnar
    30 Cavnar
  5. William Douglas Tap
    375 Tap